• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech High Growth Potential Companies
168 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

EVOK

Evoke Pharma
US$0.60-2.9%-73.9%US$5.1mUS$7.00PE-0.7xE101.6%n/a

OLK

Olink Holding
US$24.311.6%6.6%US$3.0bUS$26.00PS19xE51.4%n/a

SPRY

ARS Pharmaceuticals
US$8.65-5.6%14.0%US$834.7mUS$19.00PS27824.6xE56.2%n/a

ASND

Ascendis Pharma
US$145.02-2.5%38.2%US$8.2bUS$179.31PS28.5xE64.7%n/a

HALO

Halozyme Therapeutics
US$40.08-1.9%16.2%US$5.1bUS$50.70PE18.1xE20.8%n/a

SRPT

Sarepta Therapeutics
US$127.543.6%-2.0%US$12.0bUS$164.33PS9.6xE41.9%n/a

MGTX

MeiraGTx Holdings
US$6.360.2%25.2%US$408.4mUS$21.60PS29.1xE52.8%n/a

CAPR

Capricor Therapeutics
US$6.38-0.2%54.9%US$200.3mUS$21.00PS8xE59.4%n/a

TBPH

Theravance Biopharma
US$8.923.2%-15.2%US$429.6mUS$14.00PS7.5xE56.8%n/a

BFRI

Biofrontera
US$1.20-22.6%-90.3%US$6.1mUS$16.00PB1.3xE65.8%n/a

PGEN

Precigen
US$1.40-2.4%45.3%US$347.2mUS$9.00PS55.8xE55.5%n/a

MDWD

MediWound
US$15.97-0.2%31.8%US$147.8mUS$28.50PS7.9xE61.0%n/a

CRMD

CorMedix
US$3.922.9%15.0%US$215.5mUS$13.00PB3.1xE59.6%n/a

SPPI

Spectrum Pharmaceuticals
US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

VRCA

Verrica Pharmaceuticals
US$5.014.4%-23.3%US$212.5mUS$13.60PS41.5xE61.6%n/a

IVVD

Invivyd
US$4.3621.1%232.8%US$518.2mUS$7.67PB2.1xE57.4%n/a

INCY

Incyte
US$56.98-2.4%-18.9%US$12.8bUS$76.01PE21.4xE20.1%n/a

NBIX

Neurocrine Biosciences
US$141.431.7%45.7%US$14.1bUS$151.79PE56.4xE26.5%n/a

PRPH

ProPhase Labs
US$5.8415.9%-26.9%US$105.4mUS$20.00PS2.3xE67.1%5.1%

SBFM

Sunshine Biopharma
US$0.059-1.7%-92.4%US$5.9mUS$3.00PB0.3xE127.4%n/a

OCUP

Ocuphire Pharma
US$2.036.8%-45.0%US$50.4mUS$19.50PS2.6xE12.1%n/a

AMYT

Amryt Pharma
US$14.700.7%86.5%US$940.7mUS$20.75PS3.9xE53.9%n/a

ACER

Acer Therapeutics
US$0.80-5.4%-30.0%US$19.7mn/aPE-0.5xE66.2%n/a

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a
Page 2 of 7
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.